CHE - Chemed Corporation
Chemed (NYSE: CHE - Get Free Report) is expected to be releasing its Q3 2026 results after the market closes on Tuesday, October 27th. Analysts expect the company to announce earnings of $6.39 per share and revenue of $685.04 million for the quarter. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Investors may visit
Chemed Corporation (NYSE: CHE - Get Free Report) has received an average rating of "Hold" from the seven research firms that are presently covering the firm, Marketbeat.com reports. Five equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 1-year target price among
CINCINNATI, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the third quarter ended September 30, 2026, on Tuesday, October 27, 2026, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m.
Corient Private Wealth LP raised its stake in shares of Chemed Corporation (NYSE: CHE) by 43.8% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,882 shares of the company's stock after purchasing an additional 1,488 shares during the
Chemed (NYSE: CHE - Get Free Report) and Mangoceuticals (NASDAQ: MGRX - Get Free Report) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, valuation, dividends, institutional ownership and analyst recommendations. Volatility and Risk Chemed has a beta of 0.51, suggesting
Waverly Advisors LLC acquired a new stake in Chemed Corporation (NYSE: CHE) in the undefined quarter, according to its most recent disclosure with the SEC. The fund acquired 1,173 shares of the company's stock, valued at approximately $546,000. A number of other institutional investors have also recently modified their holdings of CHE. Eukles
CINCINNATI, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Roto-Rooter Services Company, a wholly owned subsidiary of Chemed Corporation ("Chemed") (NYSE: CHE) announced it has acquired the largest independent Roto-Rooter franchise, serving a population of approximately 11 million people, for $60.6 million.
Chemed Corporation (CHE) Presents at 2026 Jefferies Healthcare Services and Technology Conference Transcript
Amundi increased its position in Chemed Corporation (NYSE: CHE) by 51.5% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 53,856 shares of the company's stock after purchasing an additional 18,301 shares during the period. Amundi owned about 0.41% of Chemed worth $25,083,000 at the
CINCINNATI, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will deliver a presentation at the Jefferies 2026 Healthcare Services and Technology Conference on Tuesday, September 15, 2026, at approximately 10:55 a.m.
The sale occurred on Aug. 21 and was valued at approximately $541,000. The disposition reduced the executive's direct equity holdings by 7%.
NEW YORK--(BUSINESS WIRE)---- $CHE #NYSE--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Chemed Corporation (NYSE: CHE) failed to manage Chemed in an acceptable manner, breaching their fiduciary duties to Chemed, and whether Chemed and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know: On August 13, 2026, The Capital Forum released a report alleging t.
Bank of New York Mellon Corp acquired a new position in shares of Chemed Corporation (NYSE: CHE) in the undefined quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 94,045 shares of the company's stock, valued at approximately $43,800,000. Bank of New York Mellon Corp owned approximately
Chemed (CHE) reported earnings 30 days ago. What's next for the stock?
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Option Care (OPCH) or Chemed (CHE). But which of these two stocks presents investors with the better value opportunity right now?
Deutsche Bank AG acquired a new position in shares of Chemed Corporation (NYSE: CHE) during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 16,747 shares of the company's stock, valued at approximately $7,800,000. Deutsche Bank AG owned about 0.13% of Chemed
NEW YORK--(BUSINESS WIRE)---- $CHE #NYSE--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Chemed Corporation (NYSE: CHE) failed to manage Chemed in an acceptable manner, breaching their fiduciary duties to Chemed, and whether Chemed and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know: On August 13, 2026, The Capital Forum released a report alleging t.
Abacus FCF Advisors LLC acquired a new stake in shares of Chemed Corporation (NYSE: CHE) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 8,239 shares of the company's stock, valued at approximately $3,837,000. Abacus FCF Advisors LLC owned
Chemtrade Logistics Income Fund (CHE.UN:CA) Q2 2026 Earnings Call Transcript
CINCINNATI, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 70-cents per share on the Company's capital stock, payable on September 3, 2026, to shareholders of record as of August 17, 2026. This is a 10-cent, or 17%, increase over the 60-cent dividend paid in June 2026.